ATE47595T1 - Kohlenhydrat-derivate und diese enthaltende zusammensetzungen fuer therapeutische oder diagnostische verwendung. - Google Patents

Kohlenhydrat-derivate und diese enthaltende zusammensetzungen fuer therapeutische oder diagnostische verwendung.

Info

Publication number
ATE47595T1
ATE47595T1 AT84850084T AT84850084T ATE47595T1 AT E47595 T1 ATE47595 T1 AT E47595T1 AT 84850084 T AT84850084 T AT 84850084T AT 84850084 T AT84850084 T AT 84850084T AT E47595 T1 ATE47595 T1 AT E47595T1
Authority
AT
Austria
Prior art keywords
residue
hydrogen
compounds
compositions containing
carbohydrate
Prior art date
Application number
AT84850084T
Other languages
English (en)
Inventor
Bengt Andersson
Hakon Leffler
Goeran Magnusson
Eden Catharina Svanborg
Original Assignee
Bengt Andersson
Hakon Leffler
Eden Catharina Svanborg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Andersson, Hakon Leffler, Eden Catharina Svanborg filed Critical Bengt Andersson
Application granted granted Critical
Publication of ATE47595T1 publication Critical patent/ATE47595T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Socks And Pantyhose (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT84850084T 1983-03-23 1984-03-14 Kohlenhydrat-derivate und diese enthaltende zusammensetzungen fuer therapeutische oder diagnostische verwendung. ATE47595T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8301609A SE8301609D0 (sv) 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
EP84850084A EP0126043B1 (de) 1983-03-23 1984-03-14 Kohlenhydrat-Derivate und diese enthaltende Zusammensetzungen für therapeutische oder diagnostische Verwendung

Publications (1)

Publication Number Publication Date
ATE47595T1 true ATE47595T1 (de) 1989-11-15

Family

ID=20350499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84850084T ATE47595T1 (de) 1983-03-23 1984-03-14 Kohlenhydrat-derivate und diese enthaltende zusammensetzungen fuer therapeutische oder diagnostische verwendung.

Country Status (10)

Country Link
EP (1) EP0126043B1 (de)
JP (1) JPS59176300A (de)
AT (1) ATE47595T1 (de)
AU (1) AU566286B2 (de)
DE (1) DE3480288D1 (de)
DK (1) DK160484A (de)
FI (1) FI841161L (de)
IL (1) IL71239A (de)
NO (1) NO163656C (de)
SE (1) SE8301609D0 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
EP0287029A2 (de) * 1987-04-14 1988-10-19 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von Monosacchariden und/oder diese Monosaccharide enthaltenden Glykokonjugaten zur Behandlung von Infektionen durch Krankheitserreger
SE463314B (sv) * 1989-03-01 1990-11-05 Biocarb Ab Sampolymerer av en n-acylerad glykosylamin och en amid, n-akryloyl-eller metakryloylglykosylaminer samt foerfarande foer framstaellning av dessa
DK0553113T3 (da) * 1990-08-02 1999-08-09 Antex Biolog Inc Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer
US5718909A (en) * 1991-02-18 1998-02-17 Medscand Ab Sheet containing carbohydrate derivative for removal of E. coli
SE469256B (sv) * 1991-02-18 1993-06-14 Medscand Ab Rengoeringsprodukt
DE69319771T2 (de) * 1992-03-31 1999-04-22 Dai Nippon Printing Co., Ltd., Tokio/Tokyo Immobilisierte Enzym-Elektrode, Zusammensetzung zu ihrer Herstellung und elektrisch leitfähige Enzyme
US5401723A (en) * 1992-12-02 1995-03-28 Colgate-Palmolive Company Glycoconjugate inhibition of Streptococcus pyrogenes adhesion
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JP4913272B2 (ja) * 1999-01-07 2012-04-11 生化学工業株式会社 オリゴ糖の製造方法ならびに新規オリゴ糖およびそれを含む医薬組成物
US6737524B2 (en) 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
ATE361101T1 (de) 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
SE8000658L (sv) * 1980-01-28 1981-07-29 Sigfried Edvin Svensson Isolering av kolhydrater ur cellvevnad
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
JPS57500609A (de) * 1980-05-09 1982-04-08
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater

Also Published As

Publication number Publication date
DK160484A (da) 1984-09-24
EP0126043B1 (de) 1989-10-25
NO163656B (no) 1990-03-19
JPS59176300A (ja) 1984-10-05
AU566286B2 (en) 1987-10-15
FI841161A7 (fi) 1984-09-24
IL71239A (en) 1993-05-13
SE8301609D0 (sv) 1983-03-23
EP0126043A1 (de) 1984-11-21
FI841161A0 (fi) 1984-03-22
NO163656C (no) 1990-06-27
DK160484D0 (da) 1984-03-20
IL71239A0 (en) 1984-06-29
AU2587184A (en) 1984-09-27
DE3480288D1 (en) 1989-11-30
NO841135L (no) 1984-09-24
FI841161L (fi) 1984-09-24

Similar Documents

Publication Publication Date Title
ATE47595T1 (de) Kohlenhydrat-derivate und diese enthaltende zusammensetzungen fuer therapeutische oder diagnostische verwendung.
DE3881246D1 (de) Durch benzhydryl n-substituierte heterocyclische derivate, ihre herstellung und ihre verwendung.
ATE139783T1 (de) Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
DE69301897D1 (de) Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimitteln
NZ227421A (en) 1,4,7,10-tetraazacyclododecane derivatives and diagnosis using nmr
ATE59646T1 (de) 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
FI104178B1 (fi) 17-spirofuran-3'-ylideenisteroidit
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE73445T1 (de) 1,2,5,6-tetrahydropyridinoxim-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen.
DE59207425D1 (de) Imidazolylmethyl-Pyridine
ATE71938T1 (de) 1,2,5,6-tetrahydropyridin-3-carboxaldehydoximderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen.
SE8406626D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
ATE70842T1 (de) Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer.
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
PT87808A (pt) Procede de preparation de nouveaux derives de 1-arylsulfonyl 1,5-dihydro 2h-pirrol 2-one